Increased expression of hypoxia-inducible factor 1α in coeliac disease

Pediatric Research

Volumn 68, Issue 2, 2010, Pages 118-122

  Vannay, Ádám ^a   Sziksz, Erna ^a   PRókai, Á ^a   Veres, Gábor ^a   Molnár, Kriszta ^a   SZAKál, Dorottya Nagy ^a   ÓNóldy, Anna ^a   Korponay Szabó, Ilma R ^b   Szabó, András ^a   Tulassay, Tivadar ^a   ARATó, András ^a   Szebeni, Beáta ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; TREFOIL FACTOR 1; UNCLASSIFIED DRUG; ABCB1 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MULTIDRUG RESISTANCE PROTEIN; NT5E PROTEIN, HUMAN; TFF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ARTICLE; CELIAC DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; DUODENUM MUCOSA; GENE MUTATION; HUMAN; HUMAN TISSUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; BIOPSY; CYTOLOGY; DUODENUM; FEMALE; GENETICS; INTESTINE MUCOSA; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SURGERY;

5'-NUCLEOTIDASE; ADOLESCENT; BIOPSY; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DUODENUM; FEMALE; GPI-LINKED PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTESTINAL MUCOSA; MALE; P-GLYCOPROTEIN; P-GLYCOPROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 77955145363     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181e5bc96     Document Type: Article

References (41)

1. Johnston SD, Watson RG, McMillan SA, Sloan J, Love AH 1997 Prevalence of coeliac disease in Northern Ireland. Lancet 350:1370
2. Sanders DS, Patel D, Stephenson TJ, Ward AM, McCloskey EV, Hadjivassiliou M, Lobo AJ 2003 A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 15:407-413
3. West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, Reader R, Holmes GK, Khaw KT 2003 Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 52:960-965
4. Fasano A, Berti I, Geraduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horvath K 2003 Prevalence of coeliac disease in at-risk and not-at-risk groups in the United States. Arch Int.ern Med 163:286-292
5. Stepniak D, Koning F 2006 Celiac disease-sandwiched between innate and adaptive immunity. Hum Immunol 67:460-468
6. Koning F 2005 Celiac disease: caught between a rock and a hard place. Gastroenterology 129:1294-1301
7. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford K, Narravula S, Podolsky DK, Colgan SP 2001 Hypoxia-inducible factor 1-dependent induction of Int.estinal trefoil factor protects barrier function during hypoxia. J Exp Med 193:1027-1034
8. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP 2002 Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in Int.estinal epithelia. J Clin Invest 110:993-1002
9. Adams JM, Difazio LT, Rolandelli RH, Lujan JJ, Hasko G, Csoka B, Selmeczy Z, Nemeth ZH 2009 HIF-1: a key mediator in hypoxia. Acta Physiol Hung 96:19-28
10. Salceda S, Caro J 1997 Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272:22642-22647
11. Wenger RH, Stiehl DP, Camenisch G 2005 Int.egration of oxygen signaling at the consensus HRE. Sci STKE 2005:re12
12. Hoffmann W 2005 Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol Life Sci 62:2932-2938
13. Colgan SP, Eltzschig HK, Eckle T, Thompson LF 2006 Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2:351-360
14. Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A 2006 Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol 12:3636-3644
15. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH 2004 Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114:1098-1106
16. Hirota SA, Beck PL, MacDonald JA 2009 Targeting hypoxia-inducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel disease. Recent Pat Inflamm Allergy Drug Discov 3:1-16
17. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK 1990 Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 65:909-911
18. Setty M, Hormaza L, Guandalini S 2008 Celiac disease: risk assessment, diagnosis, and monitoring. Mol Diagn Ther 12:289-298
19. Leeds JS, Hopper AD, Sanders DS 2008 Coeliac disease. Br Med Bull 88:157-170
20. Koning F, Gilissen L, Wijmenga C 2005 Gluten: a two-edged sword. Immunopatho-genesis of celiac disease. Springer Semin Immunopathol 27:217-232
21. Szebeni B, Veres G, Dezsofi A, Rusai K, Vannay A, Bokodi G, Vasarhelyi B, Korponay-Szabó IR, Tulassay T, Arato A 2007 Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease. J Pediatr Gastroenterol Nutr 45:187-193
22. Groschwitz KR, Hogan SP 2009 Int.estinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 124:3-20
23. Weidemann A, Johnson RS 2008 Biology of HIF-1alpha. Cell Death Differ 15:621-627
24. Yee Koh M, Spivak-Kroizman TR, Powis G 2008 HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci 33:526-534
25. Dehne N, Brüne B 2009 HIF-1 in the inflammatory microenvironment. Exp Cell Res 315:1791-1797
26. 2 tension. Proc Natl Acad Sci USA 92:5510-5514
27. Ziello JE, Jovin IS, Huang Y 2007 Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic Int.ervention in malignancy and ischemia. Yale J Biol Med 80:51-60
28. Taylor CT, Colgan SP 2007 Hypoxia and gastroInt.estinal disease. J Mol Med 85:1295-1300
29. Cummins EP, Seeballuck F, Keely SJ, Mangan NE, Callanan JJ, Fallon PG, Taylor CT 2008 The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134:156-165
30. Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, Gonzalez FJ 2008 Hypoxia inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 134:2036-2048, 2048.e1-2048.e3
31. Robinson A, Keely S, Karhausen J, Gerich ME, Furuta GT, Colgan SP 2008 Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134:145-155
32. Noyer CM, Brandt LJ 1999 Hyperbaric oxygen therapy for perineal Crohn's disease. Am J Gastroenterol 94:318-321
33. Buchman AL, Fife C, Torres C, Smith L, Aristizibal J 2001 Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol 33:337-339
34. Agarwal S, Mayer L 2010 GastroInt.estinal manifestations in primary immune disorders. Inflamm Bowel Dis 16:703-711
35. Wong WM, Playford RJ, Wright NA 2000 Peptide gene expression in gastroInt.estinal mucosal ulceration: ordered sequence or redundancy? Gut 46:286-292
36. Tarnawski A, Szabo IL, Husain SS, Soreghan B 2001 Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. J Physiol (Paris) 95:337-344
37. Hoffmann W 2004 Trefoil factor family (TFF) peptides: regulators of mucosal regeneration and repair, and more. Peptides 25:727-730
38. Linden J 2001 Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41:775-787
39. Weissmuller T, Eltzschig HK, Colgan SP 2005 Dynamic purine signaling and metabolism during neutrophil-endothelial Int.eractions. Purinergic Signal 1:229-239
40. Schinkel AH 1997 The physiological function of drug-transporting P-glycoproteins. Semin Cancer Biol 8:161-170
41. Marzolini C, Paus E, Buclin T, Kim RB 2004 Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 75:13-33